Halozyme Therapeutics Inc (NASDAQ:HALO)

16.86
Delayed Data
As of Apr 24
 -0.085 / -0.50%
Today’s Change
6.88
Today|||52-Week Range
17.27
+74.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-19.8M-53.6M-83.5M-68.4M
 
 
 
 
 
Depreciation1.1M1.1M1.2M1.8M
 
 
 
 
 
Total Other Cash Flow5.6M8.4M10.8M19.0M
 
 
 
 
 
Funds From Operations-13.1M-44.1M-71.4M-47.6M
 
 
 
 
 
Funds From/For Other Operating Expenses21.2M20.2M-22.2M-106.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-34.4M-64.3M-49.2M-47.5M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-48.9M-88.9M
 
 
 
Decrease In Investments0.000.003.4M57.3M
 
 
 
Capital Expenditures-828.5K-1.4M-2.3M-1.4M
 
 
 
 
 
Net Cash Flow Investing-828.5K-1.4M-47.9M-33.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.0029.7M20.0M0.00
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale4.7M83.2M5.1M114.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing4.7M112.8M25.1M114.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash-30.4M47.1M-72.0M34.0M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account